Glutathione deficiency in Parkinsons disease: a review of the literature
Plus, we work with a third-party laboratory that test our each batches of our products at multiple stages during production, from raw material to finished products, to ensures compliance, standards, and consistency
A 1987 study on mice determined oral glutathione to be nontoxic,27 and a 2017 toxicity study (also on mice) found that glutathione's LD (the amount of a substance needed to kill 50% of all test animals in one dose) was 5g/kg.6 An equivalent toxic dose for an 80kg human would be 32.5g, which is more than 32 times the highest amounts used in clinical studies
We introduce glutathione directly into the bloodstream through an intravenous push (IV push) or drip
NAD+ plays a key role in cellular energy production and metabolic function, while L-Glutathione is widely recognised for its role in antioxidant defence and supporting the bodys natural detoxification pathways
For example, a 2011 study in rats found that the peptide successfully healed various lesions and promoted healthy weight gain in models of short-bowel syndrome.14 Additionally, as researchers note in the aforementioned 2016 review on BPC-157 and the gut-brain axis, BPC 157 was successful in the therapy of GI tract, periodontitis, liver and pancreas lesions, and in the healing of various tissues and wounds. Its also written in the review that the peptide acts as a mediator of Roberts cytoprotection, defined as the counteraction of the lesions arising from direct detrimental contact with a noxious agent.7 15 Insider Tip: Though there has been some small-scale positive human research on BPC-157, most of the peptides potential uses are based on the outcomes of animal or cell studies
